Translational Cardiovascular Research for Patient Benefit – Progress through Collaboration

You are invited to the first Research Grand Rounds of 2026 on “Translational Cardiovascular Research for Patient Benefit – Progress through Collaboration”. 

About the Event 

Discover how we are pushing the frontiers of cardiovascular research in Singapore! From the CArdiovascular DiseasE National Collaborative Enterprise (CADENCE)’s national effort to integrate expertise, platforms, and infrastructure to accelerate meaningful progress in heart research and innovation to patient-specific induced pluripotent stem cells (iPSCs) disease-modelling platform for heart failure. 

Join Prof Hausenloy and Asst Prof Ramachandra as they share how these developments are accelerating cardiovascular research and innovation. 

About the Speakers 

Prof Derek Hausenloy is a Director of the National Heart Research Institute Singapore (NHRIS) and Senior Consultant at the Department of Cardiology at National Heart Centre Singapore (NHCS). He is also a Professor in the Cardiovascular and Metabolic Disorders Signature Research Programme at Duke-NUS Medical School. He is an Executive Director of the CADENCE National Clinical Translation Programme, a national platform for cardiovascular research with focus on data science, clinical trials and AI/digital health.  Prof Hausenloy is an NMRC STaR Investigator Award who conducts basic, translational and clinical research in the areas of ischaemic heart disease, heart failure, cardioprotection, and cardiac magnetic resonance imaging (MRI).  

 Asst Prof Chrishan Ramachandra is a Principal Investigator at the NHRIS and Assistant Professor in the SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme. His research focuses on modelling cardiac diseases using induced pluripotent stem cells (iPSCs) to discover personalised therapeutics and new treatment targets for heart failure. He has made significant contributions to understanding signalling pathways that regulate iPSC cardiomyocyte differentiation and maturation. More recently, he has established patient-specific iPSC models of cardiometabolic disease to discover and validate new treatment strategies. Asst Prof Ramachandra has received multiple awards and positions on editorial boards of scientific journals.    

About the Facilitator 

Prof Wang Yibin is the Director of Cardiovascular and Metabolic Disorders Signature Research Programme at Duke-NUS Medical School. His research focuses on the genetic networks and molecular basis of cardiovascular and metabolic physiology and diseases since 1998. Prof Wang has a long track record in investigating stress-signal transduction, genomic and post-transcriptional regulation and metabolic modulation. Currently, he is supported by MOE, NMRC, and Tanoto Foundation Professorship, and has received Basic Researcher Award from American Heart Association with more than 280 scientific articles published. 

Registration Details 

Sign up here now or scan the QR code in the poster below.